Serum levels of interleukin-6 and Vitamin D at the onset of multiple sclerosis and neuromyelitis optica: A pilot study

BACKGROUND: Interleukin-6 (IL-6) is an important mediator in the acute phase of inflammatory diseases such as neuromyelitis optica (NMO) and multiple sclerosis (MS). The level of IL-6 is higher in cerebrospinal fluid and serum of NMO patients compare to MS. Vitamin D has a regulatory effect on IL-6,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashtari, Fereshteh, Madanian, Reyhanehsadat, Zarkesh, Sayyed Hamid, Ghalamkari, Arshia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639709/
https://www.ncbi.nlm.nih.gov/pubmed/36353347
http://dx.doi.org/10.4103/jrms.jrms_796_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639709/
https://www.ncbi.nlm.nih.gov/pubmed/36353347
http://dx.doi.org/10.4103/jrms.jrms_796_21

Ejemplares similares